FR2349590B1 - - Google Patents

Info

Publication number
FR2349590B1
FR2349590B1 FR7712795A FR7712795A FR2349590B1 FR 2349590 B1 FR2349590 B1 FR 2349590B1 FR 7712795 A FR7712795 A FR 7712795A FR 7712795 A FR7712795 A FR 7712795A FR 2349590 B1 FR2349590 B1 FR 2349590B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7712795A
Other versions
FR2349590A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Glaxo Laboratories Ltd
Original Assignee
Laboratoires Glaxo SA
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA, Glaxo Laboratories Ltd filed Critical Laboratoires Glaxo SA
Publication of FR2349590A1 publication Critical patent/FR2349590A1/fr
Application granted granted Critical
Publication of FR2349590B1 publication Critical patent/FR2349590B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7712795A 1976-04-28 1977-04-27 Forme cristalline du sel de la l-lysine et du cefuroxime, son procede de preparation et son application therapeutique Granted FR2349590A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB17307/76A GB1575905A (en) 1976-04-28 1976-04-28 Salt of cefuroxime

Publications (2)

Publication Number Publication Date
FR2349590A1 FR2349590A1 (fr) 1977-11-25
FR2349590B1 true FR2349590B1 (fr) 1980-09-05

Family

ID=10092887

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7712795A Granted FR2349590A1 (fr) 1976-04-28 1977-04-27 Forme cristalline du sel de la l-lysine et du cefuroxime, son procede de preparation et son application therapeutique

Country Status (13)

Country Link
US (1) US4128715A (fr)
JP (1) JPS533511A (fr)
AU (1) AU511722B2 (fr)
BE (1) BE854012A (fr)
DE (1) DE2718730A1 (fr)
FR (1) FR2349590A1 (fr)
GB (1) GB1575905A (fr)
IE (1) IE45036B1 (fr)
IL (1) IL51956A (fr)
NL (1) NL7704599A (fr)
NZ (1) NZ183948A (fr)
PH (1) PH13189A (fr)
ZA (1) ZA772525B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU42325B (en) * 1979-02-15 1988-08-31 Glaxo Group Ltd Process for obtaining sodium cefuroxim
ES8502863A1 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
JPS6430517U (fr) * 1987-08-14 1989-02-23
AT411996B (de) * 2000-09-11 2004-08-26 Sandoz Ag Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes
US7009813B2 (en) * 2003-05-05 2006-03-07 Hitachi Global Storage Technologies Netherlands B.V. Apparatus and method of configuring the air bearing surfaces of sliders in disk drives for producing high temperatures in thermally-assisted recordings
CN101830914B (zh) * 2010-06-04 2012-03-21 深圳九福药业科技有限公司 头孢呋辛赖氨酸结晶化合物及其制备方法
CN103130821B (zh) * 2013-03-29 2016-05-04 山东罗欣药业集团股份有限公司 一种头孢呋辛赖氨酸及其制剂
CN103145734B (zh) * 2013-03-29 2016-05-04 山东罗欣药业集团股份有限公司 一种头孢呋辛赖氨酸及其制剂
CN103159784B (zh) * 2013-03-29 2015-09-09 山东罗欣药业集团股份有限公司 一种头孢呋辛赖氨酸及其制剂
CN103130820B (zh) * 2013-03-29 2015-08-05 山东罗欣药业集团股份有限公司 一种头孢呋辛赖氨酸的合成方法
CN103159785B (zh) * 2013-03-29 2015-09-23 山东罗欣药业集团股份有限公司 一种头孢呋辛赖氨酸及其制剂
CN104940158B (zh) * 2015-06-09 2018-05-15 合肥聚信医药科技有限公司 一种含有头孢呋辛酯的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3974153A (en) * 1971-05-14 1976-08-10 Glaxo Laboratories Limited 7-Hydrocarbonoxy imino-acetamido-3-carbamoyloxy methylceph-3-em-4 carboxylic acids
US3984403A (en) * 1972-06-30 1976-10-05 Takeda Chemical Industries, Ltd. Arginine and lysine salts of acid cephalosporins

Also Published As

Publication number Publication date
FR2349590A1 (fr) 1977-11-25
IE45036B1 (en) 1982-06-02
NZ183948A (en) 1979-12-11
PH13189A (en) 1980-01-16
US4128715A (en) 1978-12-05
JPS533511A (en) 1978-01-13
ZA772525B (en) 1978-04-26
IL51956A0 (en) 1977-06-30
DE2718730A1 (de) 1977-11-17
IL51956A (en) 1980-01-31
GB1575905A (en) 1980-10-01
BE854012A (fr) 1977-10-27
NL7704599A (nl) 1977-11-01
AU2458477A (en) 1978-11-02
AU511722B2 (en) 1980-09-04
IE45036L (en) 1977-10-28

Similar Documents

Publication Publication Date Title
FR2356332B1 (fr)
DE2652133C2 (fr)
DK141496C (fr)
JPS5634028Y2 (fr)
DK131677A (fr)
DE2605401C3 (fr)
DK138771C (fr)
DK135905C (fr)
CS177780B1 (fr)
CS178386B1 (fr)
CH606961A5 (fr)
CH611512A5 (fr)
CH597549A5 (fr)
CH598399A5 (fr)
CH598779A5 (fr)
CH598932A5 (fr)
CH598954A5 (fr)
CH599091A5 (fr)
CH599612B5 (fr)
CH599714A5 (fr)
CH600826A5 (fr)
CH604783A5 (fr)
CH606824A5 (fr)
CH606946A5 (fr)
CH595237A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse